IGX PLEX RHEUMATOID ARTHRITIS (RA) ASSAY AND SQIDWORKS DIAGNOSTICS PLATFORM— 510(k) K083080

Substantially Equivalent

Sqi Diagnostics Systems

FDA 510(k) clearance K083080 for IGX PLEX RHEUMATOID ARTHRITIS (RA) ASSAY AND SQIDWORKS DIAGNOSTICS PLATFORM, Substantially Equivalent on 2009-10-29. Applicant: Sqi Diagnostics Systems.

Clearance details

Applicant: Sqi Diagnostics Systems
Product code: Code DHR
Advisory panel: Immunology
Date received: 2008-10-16
Decision date: 2009-10-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Toronto, On, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.